Kane Elfman
@kelfman
Brief19.com editor-in-chief in the The Atlantic today ⬇️
There’s one metric that can help us know when it is safe to re-open. This evening, Carlos del Rio and I propose what that is in The The Washington Post. It is tracking all deaths of ALL CAUSES. washingtonpost.com/opinions/2020/… Thread...
Today’s Brief19, your daily roundup of SARS-CoV-2. reviews the latest evidence on hydroxychloroquine in #COVID19, which finds no benefit. For more on this, and for daily updates on COVID-19 research and policy, visit: bit.ly/3alEoap
🔆Brief19 is looking for a couple of volunteers to help us with social media!🔆 🔆Science or medicine background helps but isn’t required🔆 🔆A desire to spread good medical and scientific information (and stop the spread of covid-19) is required!🔆 Email [email protected]🙌
We have have had 30+ writers! I'm so appreciative of Fred Milgrim for writing/editing and other experts like Michael Chary MD, PhD Onyeka Otugo MD, MPH Lauren Westafer, DO MPH MS Miranda Yaver, PhD Bernard P. Chang MD PhD Aida and many more! Check them out (thanks to webmaster Kane Elfman) brief19.com/team
Nine months ago, we started Brief19, your daily roundup of SARS-CoV-2. on a whim because we needed it ourselves. Frontline providers and experts, getting accurate reliable information directly to you all! So proud that thousands get the daily email (free: brief19.com/subscribe/) and visit us online weekly!
Nearly one year of Brief19, your daily roundup of SARS-CoV-2.. Started it with Joshua Kimi Chernoby, MD JD MA Kane Elfman to fill a void; bringing frontline expertise/reliable data to the public. We’ve never missed a weekday (>250 days!). Dozens of writers. Really proud of everyone. brief19.com/subscribe/